₹55.02
Above FV▼ -68.2% against the close used
Model range ₹36.92 – ₹101.06
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Bear₹36.92Fair value₹55.02Bull₹101.06
FairClose
52-week traded range
52W low ₹99.3652W high ₹176.34
The 52-week range is measured from the stored price history, not estimated.
Trading above the consensus fair value
Gujarat Kidney N Sup Sp L closed at ₹173.22, 214.8% above the consensus fair value of ₹55.02 drawn from 7 valuation models.
Financial DNA score 30/100 — Weak. P/E of 85.2x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
DCF Valuation
₹36.92
-78.7%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₹38.24
-77.9%
√(22.5 × EPS × BVPS)
EPS=1.97, BVPS=32.99 · outside Graham range (P/E 85.2, P/B 5.3) — asset-light, treat as a rough floor
P/E Fair Value
₹101.06
-41.7%
EPS × 51.3x (sector P/E)
EPS=1.97, Sector P/E=51.3x
EV/EBITDA
₹37.37
-78.4%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=320M
Book Value (P/B)
₹38.18
-78.0%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=32.99, ROE=11.1%, g=3%, r=10%
Reverse DCF
₹173.22
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 27.3% | Historical: 0%
Margin of Safety
₹44.06
-74.6%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=58.74, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.